Showing results (61-70 of 103) with videos related to
Sort By:
Pageof 11
Cancer Research|August 15, 1989
Elimination of malignant clonogenic breast cancer cells from human bone marrowI C Anderson, E J Shpall, D S Leslie, et al.Cancer Research|September 1, 1986
Prediction of the optimal timing of bone marrow reinfusion after high dose chemotherapyJ P Eder, R C Bast, W P Peters, et al.American Journal of Clinical Pathology|July 1, 1990
Detection of breast carcinoma cells in human bone marrow using fluorescence-activated cell sorting and conventional cytologyD S Leslie, W W Johnston, L Daly, et al.Bone Marrow Transplantation|December 1, 1995
Detection of tumor cells in the bone marrow of stage IV breast cancer patients receiving high-dose chemotherapy: the role of induction chemotherapyJ J Vredenburgh, W P Peters, G Rosner, et al.Experimental Eye Research|August 1, 1992
Expression of interleukin-1 alpha, interleukin-1 beta, and an interleukin-1 receptor antagonist in human retinal pigment epithelial cellsG J Jaffe, L Van Le, F Valea, et al.Seminars in Oncology|August 1, 1994
The use of intensive clinic support to permit outpatient autologous bone marrow transplantation for breast cancerW P Peters, M Ross, J J Vredenburgh, et al.Bone Marrow Transplantation|June 19, 1998
Successful allogeneic bone marrow transplantation in selected patients over 50 years of age--a single institution's experienceW Du, R Dansey, E M Abella, et al.Bone Marrow Transplantation|July 1, 1996
Ocular toxicity following high dose chemotherapy and autologous transplantP Rubin, C Hulette, J A Khawly, et al.Bone Marrow Transplantation|January 10, 2002
High-dose chemotherapy and CD34-selected peripheral blood progenitor cell transplantation for patients with breast cancer metastatic to bone and/or bone marrowJ L Klein, C Hamm, R D Dansey, et al.Molecular Pharmacology|January 1, 1993
High-dose chemotherapy-induced platelet defect: inhibition of platelet signal transduction pathwaysL Karolak, A Chandra, W Khan, et al.Pageof 11